Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.7M Sell
39,222
-2,722
-6% -$1.1M 0.34% 58
2026
Q1
$14.2M Sell
41,944
-4,418
-10% -$1.52M 0.27% 53
2025
Q4
$14.1M Sell
46,362
-23,561
-34% -$6.91M 0.3% 55
2025
Q3
$19.5M Sell
69,923
-7,713
-10% -$1.89M 0.44% 47
2025
Q2
$17.6M Sell
77,636
-55,373
-42% -$10.3M 0.55% 34
2025
Q1
$22.1M Buy
133,009
+29,305
+28% +$5.69M 0.69% 34
2024
Q4
$20.5M Buy
103,704
+26,686
+35% +$5.16M 0.71% 32
2024
Q3
$13.4M Sell
77,018
-11,853
-13% -$2.02M 0.46% 39
2024
Q2
$15.4M Buy
+88,871
New +$13.5M 0.56% 32

Other funds holding TSM

Antipodes Partners's TSM Position: Q2 2026 in Review

Antipodes Partners reduced its TSMC (TSM) stake by 6.5% in Q2 2026, selling an estimated $1.1M and leaving 39,222 shares worth $18.7M. The position accounts for 0.34% of the portfolio, ranked #58.

Antipodes Partners first reported a position in TSM in Q2 2024 and has held it in 9 quarters since. The position peaked at $22.1M in Q1 2025. 3,550 funds tracked by Wall St. Rank hold TSM as of Q2 2026.

  • Antipodes Partners held 39,222 shares of TSMC worth $18.7M as of Q2 2026.
  • Antipodes Partners sold 2,722 TSMC shares in Q2 2026, an estimated $1.1M.
  • TSMC made up 0.34% of Antipodes Partners's portfolio in Q2 2026, its #58 holding.
  • Antipodes Partners first reported a position in TSMC in Q2 2024 and has held it in 9 quarters since.
  • Antipodes Partners's TSMC position peaked at $22.1M in Q1 2025.
  • 3,550 funds tracked by Wall St. Rank held TSMC as of Q2 2026.

Based on Antipodes Partners's 13F filing for Q2 2026, filed 6 Aug 2026.